- Conditions
- Diabetes Mellitus, Type 2
- Interventions
- Donepezil 5-10 Mg Oral Tablet, Placebo Oral Tablet
- Drug
- Lead sponsor
- University of Maryland, Baltimore
- Other
- Eligibility
- 51 Years and older
- Enrollment
- 7 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2019 – 2023
- U.S. locations
- 1
- States / cities
- Easton, Maryland
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results are retrieved from ClinicalTrials.gov and synchronized into the directory. Search pages remain noindex by default.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 1–24
of 149
matching trials from the live ClinicalTrials.gov search.
Local D1 index available.
- Conditions
- Parkinson Disease
- Interventions
- Donepezil, Placebo
- Drug
- Lead sponsor
- Oregon Health and Science University
- Other
- Eligibility
- 50 Years to 90 Years
- Enrollment
- 20 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2018 – 2019
- U.S. locations
- 1
- States / cities
- Portland, Oregon
- Conditions
- Alzheimer's Disease
- Interventions
- Placebo, Idalopirdine
- Drug
- Lead sponsor
- H. Lundbeck A/S
- Industry
- Eligibility
- 50 Years and older
- Enrollment
- 933 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2013 – 2016
- U.S. locations
- 46
- States / cities
- Birmingham, Alabama • Phoenix, Arizona • Little Rock, Arkansas + 40 more
- Conditions
- Alzheimer Disease, Healthy Aging
- Interventions
- BrightGo cognitive training, Standard of Care medication for early Alzheimer's Disease
- Device · Drug
- Lead sponsor
- Bright Cloud International Corp
- Industry
- Eligibility
- 65 Years to 85 Years
- Enrollment
- 14 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2022 – 2023
- U.S. locations
- 2
- States / cities
- New Brunswick, New Jersey • North Brunswick, New Jersey
- Conditions
- Memory
- Interventions
- Donepezil, Placebos
- Drug
- Lead sponsor
- Stanford University
- Other
- Eligibility
- 55 Years to 90 Years
- Enrollment
- 198 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2000 – 2007
- U.S. locations
- 1
- States / cities
- Palo Alto, California
- Conditions
- Healthy
- Interventions
- Donepezil
- Drug
- Lead sponsor
- Ranbaxy Laboratories Limited
- Industry
- Eligibility
- 18 Years to 65 Years
- Enrollment
- 36 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2009
- U.S. locations
- 1
- States / cities
- Las Vegas, Nevada
- Conditions
- Alzheimer's Disease
- Interventions
- VI-1121, Placebo
- Drug
- Lead sponsor
- VIVUS LLC
- Industry
- Eligibility
- 60 Years to 85 Years
- Enrollment
- 61 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2011 – 2013
- U.S. locations
- 11
- States / cities
- San Francisco, California • Santa Monica, California • Sunrise, Florida + 8 more
- Conditions
- Healthy Subjects
- Interventions
- Donepezil TDS, Aricept
- Combination Product · Drug
- Lead sponsor
- Corium, Inc.
- Industry
- Eligibility
- 18 Years to 55 Years
- Enrollment
- 60 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2020 – 2021
- U.S. locations
- 1
- States / cities
- San Antonio, Texas
- Conditions
- Alzheimer's Disease
- Interventions
- Donepezil, AZD3480
- Drug
- Lead sponsor
- Targacept Inc.
- Industry
- Eligibility
- 60 Years to 85 Years
- Enrollment
- 386 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2011 – 2014
- U.S. locations
- 3
- States / cities
- Phoenix, Arizona • Brooksville, Florida • Hallandale, Florida
- Conditions
- Alzheimer's Disease
- Interventions
- Rivastigmine 5 cm^2 transdermal patch, Rivastigmine 10 cm^2 transdermal patch
- Drug
- Lead sponsor
- Novartis
- Industry
- Eligibility
- 50 Years and older
- Enrollment
- 262 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2007 – 2008
- U.S. locations
- 23
- States / cities
- Sun City, Arizona • Costa Mesa, California • Fresno, California + 20 more
- Conditions
- Alzheimer Disease, Mild Cognitive Impairment, Delirium, Dementia, Amnestic, Cognitive Disorders
- Interventions
- Donepezil
- Drug
- Lead sponsor
- New York State Psychiatric Institute
- Other
- Eligibility
- 55 Years to 95 Years
- Enrollment
- 121 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2013 – 2019
- U.S. locations
- 1
- States / cities
- New York, New York
- Conditions
- Alzheimer's Disease
- Interventions
- PF-05212377 (SAM-760), Placebo
- Drug · Other
- Lead sponsor
- Pfizer
- Industry
- Eligibility
- 60 Years and older
- Enrollment
- 186 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2012 – 2015
- U.S. locations
- 40
- States / cities
- Costa Mesa, California • Imperial, California • Rancho Mirage, California + 29 more
- Conditions
- Ischemic Stroke
- Interventions
- Donepezil
- Drug
- Lead sponsor
- Mayo Clinic
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 33 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2008 – 2010
- U.S. locations
- 1
- States / cities
- Jacksonville, Florida
- Conditions
- Down Syndrome
- Interventions
- Donepezil hydrochloride (Aricept)
- Drug
- Lead sponsor
- Eisai Inc.
- Industry
- Eligibility
- 10 Years to 17 Years
- Enrollment
- 117 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2008
- U.S. locations
- 31
- States / cities
- Phoenix, Arizona • Little Rock, Arkansas • Los Angeles, California + 24 more
- Conditions
- Delirium
- Interventions
- donepezil, Placebo
- Drug
- Lead sponsor
- Beth Israel Deaconess Medical Center
- Other
- Eligibility
- 70 Years and older
- Enrollment
- 16 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2007 – 2013
- U.S. locations
- 1
- States / cities
- Boston, Massachusetts
- Conditions
- Amblyopia
- Interventions
- Donepezil, Patching
- Drug · Other
- Lead sponsor
- Boston Children's Hospital
- Other
- Eligibility
- 8 Years and older
- Enrollment
- 18 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2012 – 2021
- U.S. locations
- 3
- States / cities
- Boston, Massachusetts • Waltham, Massachusetts • Weymouth, Massachusetts
- Conditions
- Cognitive Impairment
- Interventions
- Aricept
- Drug
- Lead sponsor
- Eisai Limited
- Industry
- Eligibility
- 25 Years to 70 Years
- Enrollment
- 165 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2005 – 2007
- U.S. locations
- 2
- States / cities
- Maywood, Illinois • New York, New York
- Conditions
- Alzheimer's Disease
- Interventions
- ST101, Placebo
- Drug
- Lead sponsor
- Sonexa Therapeutics, Inc.
- Industry
- Eligibility
- 50 Years and older
- Enrollment
- 210 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2009 – 2011
- U.S. locations
- 27
- States / cities
- Tucson, Arizona • Costa Mesa, California • Redlands, California + 24 more
- Conditions
- Cognition Disorders
- Interventions
- donepezil, Placebo
- Drug
- Lead sponsor
- National Institute on Aging (NIA)
- NIH
- Eligibility
- 40 Years to 90 Years
- Enrollment
- 64 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2000 – 2007
- U.S. locations
- 1
- States / cities
- Los Angeles, California
- Conditions
- Alzheimer's Disease
- Interventions
- Donepezil TDS
- Drug
- Lead sponsor
- Corium, Inc.
- Industry
- Eligibility
- 30 Years and older
- Enrollment
- 66 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2018
- U.S. locations
- 1
- States / cities
- Tempe, Arizona
- Conditions
- Healthy Subjects
- Interventions
- Donepezil plus placebo, Donepezil, Begacestat
- Drug
- Lead sponsor
- Wyeth is now a wholly owned subsidiary of Pfizer
- Industry
- Eligibility
- 18 Years to 50 Years
- Enrollment
- 47 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2009
- U.S. locations
- 1
- States / cities
- Overland Park, Kansas
- Conditions
- Migraine Headache
- Interventions
- Aricept (donepezil hydrochloride)
- Drug
- Lead sponsor
- Eisai Inc.
- Industry
- Eligibility
- 18 Years to 65 Years
- Enrollment
- 89 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2003 – 2007
- U.S. locations
- 4
- States / cities
- Chicago, Illinois • Springfield, Missouri • Mount Vernon, New York + 1 more
- Conditions
- Visual Perception, Attention, Information Processing, Cholinergic System
- Interventions
- Donepzil, Placebo oral tablet
- Drug
- Lead sponsor
- University of California, Berkeley
- Other
- Eligibility
- 18 Years to 80 Years
- Enrollment
- 12 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2021
- U.S. locations
- 1
- States / cities
- Berkeley, California
- Conditions
- Alzheimer's Disease
- Interventions
- Dimebon, Placebo
- Drug
- Lead sponsor
- Medivation, Inc.
- Industry
- Eligibility
- 50 Years and older
- Enrollment
- 46 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2008 – 2010
- U.S. locations
- 4
- States / cities
- Los Alamitos, California • National City, California • Delray Beach, Florida + 1 more